Results 121 to 130 of about 1,228,475 (265)
Verbal and Visuospatial Working Memory Performance During the CO<sub>2</sub> Challenge Model of Anxiety. [PDF]
Dunger W, Edwards M, Board A, Garner M.
europepmc +1 more source
ABSTRACT Background Patients with chronic kidney disease undergoing hemodialysis commonly experience reduced physical function, fatigue, poor sleep quality, and impaired health‐related quality of life. Intradialytic exercise has been proposed as a non‐pharmacological strategy to improve these outcomes.
Klebson da Silva Almeida +6 more
wiley +1 more source
The time sensitivity of aspirational interventions: Evidence from a role-modeling RCT. [PDF]
Bhan PC, Schroeder M, Turchet D, Wen J.
europepmc +1 more source
ABSTRACT Background Maintenance hemodialysis (MHD) patients frequently suffer from frailty, characterized by reduced physical function and poor prognosis. Myokines, such as myonectin, secreted by muscle, are emerging regulators of systemic health. This study investigated the relationship between serum myonectin, adipokines (adiponectin, omentin), and ...
Kenichi Kono +7 more
wiley +1 more source
Evaluating Components of Vocal Effort in Transgender Women. [PDF]
Tang K, K Meyer T, Chang J.
europepmc +1 more source
High-definition tDCS restores adaptable neural dynamics in migraine
Majid Saberi +3 more
doaj +1 more source
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo +5 more
wiley +1 more source
Impact of Respiratory Effort Parameters on Clinical Outcomes in Respiratory Failure Patients (Effort-I): A Prospective Observational Study. [PDF]
Soipetkasem P +4 more
europepmc +1 more source
ABSTRACT Introduction This final analysis of a multicenter, prospective postmarketing surveillance study evaluated the safety of daprodustat in patients with chronic kidney disease anemia in routine clinical practice in Japan. Methods Patients who initiated daprodustat between September 2020 and July 2022 were registered.
Tadao Akizawa +7 more
wiley +1 more source

